Should you stop taking alli after the FDA added a kidney injury warning?

Short answer: probably not automatically. The FDA did not tell every current alli user to stop on June 10, 2026. It approved a new warning on the over-the-counter Drug Facts label after reviewing postmarketing reports and published literature about rare kidney stones and kidney injury linked to orlistat, the active ingredient in alli.

What matters most now is whether you have a history that raises concern, or whether you have symptoms that fit the new warning. If you do, the FDA says that is the point to stop using alli and contact a clinician.

What changed on June 10, 2026

The FDA said alli’s label now tells consumers to ask a health care provider before using the drug if they have ever had kidney disease or kidney stones. The agency also approved new symptom language telling consumers to stop use and ask a doctor if they develop signs that could suggest kidney injury or a kidney stone.

The new labeling was also confirmed in the FDA approval letter for the updated Drug Facts label, and the current NIH DailyMed version shows the same added warning language. This was a label change, not a market withdrawal or recall.

alli is the 60 mg over-the-counter form of orlistat. The current DailyMed label says it is for weight loss in overweight adults age 18 and older when used with a reduced-calorie, low-fat diet.

Who should be extra cautious before using alli

The clearest group is people who have ever had kidney disease or kidney stones. That is the group specifically named in the new FDA warning.

The label also says to check with a doctor or pharmacist before use if you take certain prescription medicines, including blood thinners, amiodarone, diabetes medicines, thyroid medicines, seizure medicines, antiretrovirals, or other weight-loss products. MedlinePlus also advises patients to mention a history of diabetes, kidney stones, pancreatitis, gallbladder disease, or thyroid disease when discussing orlistat.

Symptoms from the new warning, in plain language

The new label says to stop use and ask a doctor if you develop:

severe pain in the back or groin
painful urination
blood in the urine
swelling in the feet or legs
urinating less often than normal

Those are not the usual bowel-related side effects people may associate with orlistat. They are warning signs that could point to a kidney stone or kidney injury and should not be brushed off.

What the warning does and does not mean

It does mean the FDA saw a safety signal strong enough to change the over-the-counter label and align it with kidney warnings used for prescription orlistat products.

It does not mean kidney injury is common in everyone who takes alli. The FDA described these reports as rare. In its review of reports from alli’s approval on February 9, 2007, through December 31, 2023, the agency identified 12 kidney-complication cases associated with alli use. But the FDA also said the true number could be higher because side effects are underreported, and several reports lacked important details.

Just as important, those reports do not tell us exactly how often this happens, and they do not prove that alli was the only cause in every case. The FDA noted that some people also had obesity, diabetes, high blood pressure, or a history of kidney disease or kidney stones, which could have added to the risk.

The published clinical literature supports caution without proving broad cause and effect. For example, a BMJ Case Reports paper indexed in PubMed described two patients with orlistat-related oxalate nephropathy. Case reports can show that a problem is biologically plausible, but they cannot tell us how common it is in the general public.

So should current users stop now?

For many people, the practical answer is no blanket stop. If you are taking alli, feel well, and do not have the kidney-related symptoms on the new label, the FDA communication does not say that every current user should stop immediately.

But it is reasonable to pause and check your risk if you have ever had kidney disease or kidney stones, if you take medicines listed on the label, or if anything about your symptoms seems new or concerning. Do not make long-term treatment changes on your own; use the new warning as a reason to review the drug with a clinician or pharmacist.

What readers, caregivers, and pharmacists can do now

Read the current box or bottle label carefully. The updated Drug Facts language matters because alli is sold over the counter, so many people may start it without first seeing a prescriber.
Review kidney history before starting or restarting it. A past kidney stone, chronic kidney disease, or prior kidney injury deserves a check-in before use.
Know which symptoms change the plan. Back or groin pain, painful urination, blood in the urine, leg or foot swelling, or urinating less often are not symptoms to ignore for long.
Ask about drug interactions and safe use. Keep a current medicine list handy for a pharmacist or clinician review.
Get urgent care quickly if symptoms are severe, worsening, or you cannot pass urine. That is especially important if pain is intense or swelling is increasing.
Report suspected side effects. The FDA encourages consumers and health professionals to report problems through MedWatch.

The bottom line: the new warning is a reason to pay attention, not a reason for panic. For most readers, the safest next step is not guessing. It is matching the new FDA warning to your own history, symptoms, and medication list, then checking with a clinician or pharmacist if any of those raise concern.

Sources

Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.

This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.